Belrapzo Injection
Product Images NDC 42367-521

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Belrapzo (NDC 42367-521). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Eagle Pharmaceuticals, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Belrapzo 01)

FDA Label Image

Figure 1 (Belrapzo 02)

FDA Label Image

Carton Label (Belrapzo 03)

FDA Label Image

Vial Label (front) (Belrapzo 04)

Vial Label (front) (Belrapzo 04)
Belrapzo is a medication used for intravenous infusion only, and it comes in a multi-dose vial of 100mg/4ml. The vial must be stored in a refrigerator between 2 to 8°C and retained in its original carton. It is a sterile Rx-only product marketed by Eagle Pharmaceuticals, Inc, and manufactured in Italy. The required dose based on concentration should be withdrawn aseptically from the vial and diluted in 500ml of 0.9% Sodium Chloride Injection or 2.5% Dextrose/0.45% Sodium Chloride Injection before administration. However, it must not be used if solid or particulate matter is observed, and the instructions on dosing and dilution for the solution should be strictly followed.*
FDA Label Image

Vial Label (inside Of Front Label) (Belrapzo 05)

Vial Label (inside Of Front Label) (Belrapzo 05)
This is a medication called $Belrapzo or Bendamustine HCI Injection used for intravenous infusion. This medication comes in a mult-dose vial of 100mg/4ml concentration and must be diluted in a 500ml infusion bag of 0.9% Sodium Chloride Injection or 2.5% Dextrose/0.45% Sodium Chloride Injection before administration. The medication contains Bendamustine Hydrochloride and is marketed by Eagle Pharmaceuticals Inc. This medication is a cytotoxic agent and the use of gloves and safety glasses is recommended during handling and preparation. It must be stored in a refrigerator at 2 to 8°C until use to protect it from light. The packaging contains further instructions and details about usual dosage, dilution, and administration.*
FDA Label Image

Carton Label (Belrapzo 06)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.